Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Revenue (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Revenue for 4 consecutive years, with $690000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Revenue fell 96.63% to $690000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $29.6 million, a 33.0% increase, with the full-year FY2025 number at $45.0 million, up 80.0% from a year prior.
  • Revenue was $690000.0 for Q4 2025 at Lexicon Pharmaceuticals, down from $28.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $28.9 million in Q2 2025 to a low of $690000.0 in Q4 2025.